Regeneron and Intellia collaborate to discover CRISPR/Cas therapeutics
12 April 2016 | By Victoria White, Digital Content Producer
In addition to the discovery, development and commercialisation of new therapies, the companies will focus on technology development of the CRISPR/Cas platform...